Literature DB >> 18813118

Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM).

Jan-Bart M Koorstra1, Anirban Maitra, Folkert H M Morsink, Paul Drillenburg, Fiebo J W ten Kate, Ralph H Hruban, Johan A Offerhaus.   

Abstract

The familial atypical multiple mole melanoma (FAMMM) syndrome is caused by a germline mutation of p16. More than 90% of the sporadic pancreatic carcinomas contain genetic alterations that inactivate p16. Patients with the FAMMM syndrome have an increased risk of developing pancreatic cancer. Ductal adenocarcinoma is the most common cancer of the pancreas and the one encountered in patients with FAMMM syndrome. Undifferentiated carcinoma with osteoclastic giant cells, also referred to as UCOCGC of the pancreas, is a rare variant of pancreatic cancer. An UCOCGC of the pancreas associated with FAMMM syndrome is described in this report. Molecular analysis confirmed a germline p16-Leiden deletion in the UCOCGC, accompanied by somatic loss of heterozygosity of the second p16 allele, and absence of p16 protein expression in the neoplastic cells. It is the first case reported and it provides additional evidence that UCOCGC can be considered as a variant of conventional ductal adenocarcinoma of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813118      PMCID: PMC2704013          DOI: 10.1097/PAS.0b013e31818371cd

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.

Authors:  R H Hruban; P D Sturm; R J Slebos; R E Wilentz; A R Musler; C J Yeo; T A Sohn; M L van Velthuysen; G J Offerhaus
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994.

Authors:  E T Hille; E van Duijn; N A Gruis; F R Rosendaal; W Bergman; J P Vandenbroucke
Journal:  J Invest Dermatol       Date:  1998-05       Impact factor: 8.551

3.  Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin.

Authors:  J Rosai
Journal:  Cancer       Date:  1968-08       Impact factor: 6.860

4.  Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.

Authors:  A J Whelan; D Bartsch; P J Goodfellow
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

5.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Authors:  M Schutte; R H Hruban; J Geradts; R Maynard; W Hilgers; S K Rabindran; C A Moskaluk; S A Hahn; I Schwarte-Waldhoff; W Schmiegel; S B Baylin; S E Kern; J G Herman
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

6.  Molecular evidence for the same clonal origin of both components of an adenosquamous Barrett carcinoma.

Authors:  Bastiaan P van Rees; Remigio W Rouse; Mireille J de Wit; Carel J M van Noesel; Guido N J Tytgat; J Jan B van Lanschot; G Johan A Offerhaus
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

7.  Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).

Authors:  Wouter H de vos tot Nederveen Cappel; G Johan A Offerhaus; Marjo van Puijenbroek; Eric Caspers; Nelleke A Gruis; Femke A De Snoo; Cornelis B H W Lamers; Gerrit Griffioen; Wilma Bergman; Hans F A Vasen; Hans Morreau
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

8.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

9.  Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.

Authors:  A M Goldstein; M C Fraser; J P Struewing; C J Hussussian; K Ranade; D P Zametkin; L S Fontaine; S M Organic; N C Dracopoli; W H Clark
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

Review 10.  K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.

Authors:  W H Westra; P Sturm; P Drillenburg; M A Choti; D S Klimstra; J Albores-Saavedra; A Montag; G J Offerhaus; R H Hruban
Journal:  Am J Surg Pathol       Date:  1998-10       Impact factor: 6.394

View more
  7 in total

Review 1.  Molecular signatures of pancreatic cancer.

Authors:  Seung-Mo Hong; Jason Y Park; Ralph H Hruban; Michael Goggins
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.

Authors:  Chanjuan Shi; Alison P Klein; Michael Goggins; Anirban Maitra; Marcia Canto; Syed Ali; Richard Schulick; Emily Palmisano; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  A case report of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and literature review.

Authors:  Yasuhiro Togawa; Akihiko Tonouchi; Tsuyoshi Chiku; Wataru Sano; Tomoko Doki; Kentaro Yano; Hidehiko Uno; Tomohiro Muronoi; Katsuhiko Kaneoya; Takashi Shinagawa; Kenichi Harigaya; Akihiro Toyoda
Journal:  Clin J Gastroenterol       Date:  2010-07-09

4.  Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis.

Authors:  Guangjian Yang; Jiangxia Yin; Kai Ou; Qiang Du; Wenhao Ren; Yujing Jin; Liming Peng; Lin Yang
Journal:  BMC Gastroenterol       Date:  2020-06-26       Impact factor: 3.067

Review 5.  Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.

Authors:  Chiara Bazzichetto; Claudio Luchini; Fabiana Conciatori; Vanja Vaccaro; Ilaria Di Cello; Paola Mattiolo; Italia Falcone; Gianluigi Ferretti; Aldo Scarpa; Francesco Cognetti; Michele Milella
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

6.  KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant.

Authors:  Huijun Wang; Yanyan Qian; Bingbing Wu; Ping Zhang; Wenhao Zhou
Journal:  BMC Med Genet       Date:  2015-10-31       Impact factor: 2.103

7.  Pancreatic undifferentiated carcinoma with osteoclast-like giant cells curatively resected after pembrolizumab therapy for lung metastases: a case report.

Authors:  Miku Obayashi; Yasushi Shibasaki; Toru Koakutsu; Yoshiro Hayashi; Tsuyoshi Shoji; Kazuhisa Hirayama; Masanori Yamazaki; Yasuhiro Takayanagi; Hiroshi Shibata; Masato Nakamura; Hirotoshi Maruo
Journal:  BMC Gastroenterol       Date:  2020-07-11       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.